Is ONCO or ORMP more undervalued in 2026?

CirclFi compares Onconetix, Inc. (ONCO) and Oramed Pharmaceuticals Inc. (ORMP) using 13 institutional-grade valuation models. ONCO has a Quality of Company score of 4.5/10 while ORMP scores 7.1/10.

Which is a better buy — ONCO or ORMP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ONCO and ORMP valuations compare?

ONCO at $1.17 and ORMP at $3.96 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ONCO vs ORMP Valuation Comparison 2026 — Intrinsic Value Analysis

ONCO

Biotechnology

Onconetix, Inc.

Quality

4.5

out of 10

Value Trap

WARN

Price

$1.17

Last close

Models

9/13

Active

ORMP

Biotechnology

Oramed Pharmaceuticals Inc.

Quality

7.1

out of 10

Value Trap

SAFE

Price

$3.96

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	ONCO Fair Value	ONCO Upside	ORMP Fair Value	ORMP Upside
Bayesian DCF	Intrinsic	$1.89	+61.5%	$8.77	+121.4%
Earnings Power Value	Intrinsic	$1.51	+138.5%	$11.49	+188.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ONCO vs ORMP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ONCO vs ORMP — Which Stock Is More Undervalued?

ORMP scores higher with a 7.1/10 quality rating vs ONCO's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Onconetix, Inc. (ONCO) and Oramed Pharmaceuticals Inc. (ORMP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ONCO currently trades at $1.17 with a QOC of 4.5/10, while ORMP trades at $3.96 with a QOC of 7.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).